Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry.

[1]  M. Jeong,et al.  Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. , 2011, Journal of the American College of Cardiology.

[2]  M. Jeong,et al.  Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention , 2009, Circulation.

[3]  S. Yasuda,et al.  Improved long-term prognosis of elderly women in the era of sirolimus-eluting stents. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[4]  Eric L Eisenstein,et al.  Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. , 2009, Journal of the American College of Cardiology.

[5]  A. Colombo,et al.  Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation. , 2008, The American journal of cardiology.

[6]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[7]  Timothy J Gardner,et al.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Circulation.

[8]  C. Grines,et al.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Journal of the American College of Cardiology.

[9]  J. Jayne,et al.  Age-based differences of percutaneous coronary intervention in the drug-eluting stent era. , 2006, Journal of interventional cardiology.

[10]  H. Rdzanek.  [Commentary to the article: Montalescot G, White HD, Gallo R, et al. STEEPLE Investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention]. , 2006, Kardiologia polska.

[11]  S. Steinhubl,et al.  Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. , 2006, The New England journal of medicine.

[12]  S. Kelsey,et al.  Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. , 2003, American heart journal.

[13]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[14]  L. Klein,et al.  Percutaneous coronary interventions in octogenarians in the American College of Cardiology-National Cardiovascular Data Registry: development of a nomogram predictive of in-hospital mortality. , 2002, Journal of the American College of Cardiology.

[15]  S. Yusuf,et al.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study ☆ , 2002 .

[16]  K. Anstrom,et al.  Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. , 2000, Journal of the American College of Cardiology.

[17]  G. Stone,et al.  Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). , 2000, The American journal of cardiology.

[18]  K. Anstrom,et al.  Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. , 2000, Journal of the American College of Cardiology.

[19]  D. Wennberg,et al.  Percutaneous transluminal coronary angioplasty in the elderly: Epidemiology, clinical risk factors, and in-hospital outcomes ☆ ☆☆ ★ , 1999 .

[20]  C. Di Mario,et al.  Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up. , 1998, Journal of the American College of Cardiology.

[21]  D. Morrison,et al.  Coronary angioplasty for elderly patients with "high risk" unstable angina: short-term outcomes and long-term survival. , 1997, Journal of the American College of Cardiology.

[22]  A Bouckaert,et al.  Practical considerations on the use of the Charlson comorbidity index with administrative data bases. , 1996, Journal of clinical epidemiology.

[23]  P. Rochon,et al.  Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. , 1996, Medical care.

[24]  R. Hiatt,et al.  Comorbidity and breast cancer survival: a comparison between black and white women. , 1996, Annals of epidemiology.

[25]  R E Hall,et al.  Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data. , 1996, Journal of clinical epidemiology.

[26]  J. Vaupel,et al.  Survival after the age of 80 in the United States, Sweden, France, England, and Japan. , 1995, The New England journal of medicine.

[27]  D. Pryor,et al.  Changes in Mortality after Myocardial Revascularization in the Elderly: The National Medicare Experience , 1994, Annals of Internal Medicine.

[28]  A. Pichard,et al.  Morbidity and mortality rates in elderly patients undergoing percutaneous coronary transluminal angioplasty. , 1994, American heart journal.

[29]  J. O’Keefe,et al.  Coronary angioplasty versus bypass surgery in patients > 70 years old matched for ventricular function. , 1994, Journal of the American College of Cardiology.

[30]  J. Jollis,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. , 1993, Journal of clinical epidemiology.

[31]  A. Pichard,et al.  Late outcome and quality of life following percutaneous transluminal coronary angioplasty in octogenarians. , 1993, Catheterization and cardiovascular diagnosis.

[32]  J. Haft,et al.  Coronary angioplasty in patients eighty years of age or older. , 1992, American heart journal.

[33]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[34]  J. Wei,et al.  PTCA in the Elderly: The “Young‐Old” versus the “Old‐Old” , 1992, Journal of the American Geriatrics Society.

[35]  Randall C. Thompson,et al.  Percutaneous transluminal coronary angioplasty in the elderly: early and long-term results. , 1991, Journal of the American College of Cardiology.

[36]  J. Webb,et al.  Coronary angioplasty in octogenarians: comparisons to coronary bypass surgery. , 1991, Catheterization and cardiovascular diagnosis.

[37]  R. Gillum,et al.  Coronary heart disease and related procedures. National Hospital Discharge Survey data. , 1989, Circulation.

[38]  Randall C. Thompson,et al.  Changing outcome of angioplasty in the elderly. , 1996, Journal of the American College of Cardiology.

[39]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.